Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
H M van Praa. [The cerebral dopamine metabolism in schizophrenia]. Nederlands tijdschrift voor geneeskunde. vol 119. issue 19. 1975-10-07. PMID:1143560. |
[the cerebral dopamine metabolism in schizophrenia]. |
1975-10-07 |
2023-08-11 |
Not clear |
S Matthyss. Dopamine and the pharmacology of schizophrenia: the state of the evidence. Journal of psychiatric research. vol 11. 1975-09-05. PMID:4218872. |
dopamine and the pharmacology of schizophrenia: the state of the evidence. |
1975-09-05 |
2023-08-11 |
Not clear |
H Y Meltzer, E J Sachar, A G Frant. Dopamine antagonism by thioridazine in schizophrenia. Biological psychiatry. vol 10. issue 1. 1975-06-21. PMID:1120175. |
dopamine antagonism by thioridazine in schizophrenia. |
1975-06-21 |
2023-08-11 |
Not clear |
J Stevens, K Wilson, W Foot. GABA blockade, dopamine and schizophrenia: experimental studies in the cat. Psychopharmacologia. vol 39. issue 2. 1975-05-04. PMID:4155802. |
gaba blockade, dopamine and schizophrenia: experimental studies in the cat. |
1975-05-04 |
2023-08-11 |
cat |
D S Janowsky, J M Davi. Dopamine, psychomotor stimulants, and schizophrenia: effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics. Advances in biochemical psychopharmacology. vol 12. issue 0. 1975-01-13. PMID:4608582. |
dopamine, psychomotor stimulants, and schizophrenia: effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics. |
1975-01-13 |
2023-08-11 |
Not clear |
T B Horvath, R A Meare. L-dopa and arousal. Journal of neurology, neurosurgery, and psychiatry. vol 37. issue 4. 1974-08-28. PMID:4838912. |
it is possible that dopamine is the transmitter associated with the arousal reaction and that it plays a part in the pathogenesis of schizophrenia. |
1974-08-28 |
2023-08-11 |
Not clear |
Y C Clement-Cormier, J W Kebabian, G L Petzold, P Greengar. Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proceedings of the National Academy of Sciences of the United States of America. vol 71. issue 4. 1974-07-31. PMID:4151517. |
several different classes of drugs effective in the treatment of schizophrenia (antipsychotic drugs) were potent inhibitors of the stimulation by dopamine of the enzyme from these various regions. |
1974-07-31 |
2023-08-11 |
human |
T Hökfelt, A Ljungdahl, K Fuxe, O Johansso. Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science (New York, N.Y.). vol 184. issue 4133. 1974-05-02. PMID:4856104. |
dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. |
1974-05-02 |
2023-08-11 |
rat |
J A Smith, R Hartle. Abnormal O-methylated dopamine metabolites: the endogenous toxins of schizophrenia or parkinsonism? The Journal of pharmacy and pharmacology. vol 25. issue 5. 1973-09-28. PMID:4146400. |
abnormal o-methylated dopamine metabolites: the endogenous toxins of schizophrenia or parkinsonism? |
1973-09-28 |
2023-08-11 |
Not clear |
V C Panisset, J M Albert, L P Rocheleau, G Dhaiti, L Tétreaul. [Effects of thioproperazine on dopamine and noradrenaline metabolism in chronic schizophrenia]. Laval medical. vol 41. issue 7. 1971-06-01. PMID:4396422. |
[effects of thioproperazine on dopamine and noradrenaline metabolism in chronic schizophrenia]. |
1971-06-01 |
2023-08-11 |
Not clear |